Vinati Organics Q4 Review – Increased Growth Guidance For FY22: Systematix

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Vinati Organics Ltd. Q4 FY21 results were in line with our estimates with sales/Ebitda/adjusted profit after tax growth of 14%/down 3%/down 5% YoY and 14%/37%/10% QoQ.

Sales growth was driven by healthy volume offtake and improved realisations (up 14% YoY) for butyl phenol.

Acrylamido methylpropane sulphonic acid sales declined 11% YoY due to logistics challenges during Q4.

Despite price improvement across key products, gross margin contracted 50 basis points YoY to 59.2% due to a sharp increase in prices of raw materials such as toluene (78% YoY), acryl-o-nitrile (up 28%) and propylene (up 59%).

Click on the attachment to read the full report:

Systematix Vinati Organics – Q4FY21 Result Update.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button